A one-year cost–utility analysis of REBOA versus RTACC for non-compressible torso haemorrhage

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.